Jelusic M, Sestan M, Cimaz R, Ozen S (2019) Different histological classifications for Henoch-Schonlein purpura nephritis: which one should be used? Pediatr Rheumatol Online J 17:10. https://doi.org/10.1186/s12969-019-0311-z

Article  PubMed  PubMed Central  Google Scholar 

Samsonov D, Zolotnitskaya A, Matloff R, Pereira T, Solomon S (2022) Mycophenolate mofetil for severe IgA vasculitis nephropathy in children: an observational study. Kidney Med 4:100534. https://doi.org/10.1016/j.xkme.2022.100534

Article  PubMed  PubMed Central  Google Scholar 

Kurt-Sukur ED, Sekar T, Tullus K (2021) Biopsy-proven Henoch-Schonlein purpura nephritis: a single center experience. Pediatr Nephrol 36:1207–1215. https://doi.org/10.1007/s00467-020-04809-8

Article  PubMed  Google Scholar 

Shima Y, Mukaiyama H, Tanaka Y, Shimabukuro W, Nozu K, Kaito H, Tanaka R, Sako M, Iijima K, Tokuhara D, Yoshikawa N, Nakanishi K (2024) Factors related to recurrence of proteinuria in childhood IgA nephropathy. Pediatr Nephrol 39:463–471. https://doi.org/10.1007/s00467-023-06116-4

Article  PubMed  Google Scholar 

Counahan R, Winterborn MH, White RH, Heaton JM, Meadow SR, Bluett NH, Swetschin H, Cameron JS, Chantler C (1977) Prognosis of Henoch-Schonlein nephritis in children. Br Med J 2:11–14. https://doi.org/10.1136/bmj.2.6078.11

Article  CAS  PubMed  PubMed Central  Google Scholar 

Jauhola O, Ronkainen J, Koskimies O, Ala-Houhala M, Arikoski P, Holtta T, Jahnukainen T, Rajantie J, Ormala T, Turtinen J, Nuutinen M (2010) Renal manifestations of Henoch-Schonlein purpura in a 6-month prospective study of 223 children. Arch Dis Child 95:877–882. https://doi.org/10.1136/adc.2009.182394

Article  PubMed  Google Scholar 

Yang XQ, Huang YJ, Zhai WS, Ren XQ, Guo QY, Zhang X, Yang M, Zhang J, Ding Y, Zhu S, Yamamoto T, Sun Y (2019) Correlation between endocapillary proliferative and nephrotic-range proteinuria in children with Henoch-Schonlein purpura nephritis. Pediatr Nephrol 34:663–670. https://doi.org/10.1007/s00467-018-4134-9

Article  PubMed  Google Scholar 

Kang Z, Xun M, Li Z, Yang Z (2022) Association of the clinicopathological characteristics and proteinuria remission of pediatric IgAV with nephrotic-range proteinuria: A retrospective cohort study. Front Pediatr 10:959212. https://doi.org/10.3389/fped.2022.959212

Article  PubMed  PubMed Central  Google Scholar 

Wakaki H, Ishikura K, Hataya H, Hamasaki Y, Sakai T, Yata N, Kaneko T, Honda M (2011) Henoch-Schonlein purpura nephritis with nephrotic state in children: predictors of poor outcomes. Pediatr Nephrol 26:921–925. https://doi.org/10.1007/s00467-011-1827-8

Article  PubMed  Google Scholar 

Hennies I, Gimpel C, Gellermann J, Moller K, Mayer B, Dittrich K, Buscher AK, Hansen M, Aulbert W, Wuhl E, Nissel R, Schalk G, Weber LT, Pohl M, Wygoda S, Beetz R, Klaus G, Fehrenbach H, Konig S, Staude H, Beringer O, Bald M, Walden U, von Schnakenburg C, Bertram G, Wallot M, Haffner K, Wiech T, Hoyer PF, Pohl M; German Society of Pediatric Nephrology (2018) Presentation of pediatric Henoch-Schonlein purpura nephritis changes with age and renal histology depends on biopsy timing. Pediatr Nephrol 33:277–286.https://doi.org/10.1007/s00467-017-3794-1

Feng D, Huang WY, Hao S, Niu XL, Wang P, Wu Y, Zhu GH (2017) A single-center analysis of Henoch-Schonlein purpura nephritis with nephrotic proteinuria in children. Pediatr Rheumatol Online J 15:15. https://doi.org/10.1186/s12969-017-0146-4

Article  PubMed  PubMed Central  Google Scholar 

Tian M, Liu C (2015) Heparin calcium treated Henoch-Schonlein purpura nephritis in children through inhibiting hyperfibrinolysis. Ren Fail 37:1100–1104. https://doi.org/10.3109/0886022X.2015.1061668

Article  CAS  PubMed  Google Scholar 

Nickavar A, Mehrazma M, Lahouti A (2012) Clinicopathologic correlations in Henoch-Schonlein nephritis. Iran J Kidney Dis 6:437–440

PubMed  Google Scholar 

Cao Y, Shen T, Li Y, Shuai L, Chen Q, Mo S, Li C, Li X, Wang Y, Wu X (2022) A retrospective study on the characteristics of renal pathological grades in HSPN children with mild to moderate proteinuria. Front Pediatr 10:1029520. https://doi.org/10.3389/fped.2022.1029520

Article  PubMed  PubMed Central  Google Scholar 

Xu L, Li Y, Wu X (2022) IgA vasculitis update: Epidemiology, pathogenesis, and biomarkers. Front Immunol 13:921864. https://doi.org/10.3389/fimmu.2022.921864

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chan H, Tang YL, Lv XH, Zhang GF, Wang M, Yang HP, Li Q (2016) Risk factors associated with renal involvement in childhood Henoch-Schonlein purpura: a meta-analysis. PLoS One 11:e0167346. https://doi.org/10.1371/journal.pone.0167346

Hisano S, Matsushita M, Fujita T, Iwasaki H (2005) Activation of the lectin complement pathway in Henoch-Schonlein purpura nephritis. Am J Kidney Dis 45:295–302. https://doi.org/10.1053/j.ajkd.2004.10.020

Article  CAS  PubMed  Google Scholar 

Chua JS, Zandbergen M, Wolterbeek R, Baelde HJ, van Es LA, de Fijter JW, Bruijn JA, Bajema IM (2019) Complement-mediated microangiopathy in IgA nephropathy and IgA vasculitis with nephritis. Mod Pathol 32:1147–1157. https://doi.org/10.1038/s41379-019-0259-z

Article  CAS  PubMed  Google Scholar 

Narchi H (2005) Risk of long term renal impairment and duration of follow up recommended for Henoch-Schonlein purpura with normal or minimal urinary findings: a systematic review. Arch Dis Child 90:916–920. https://doi.org/10.1136/adc.2005.074641

Article  CAS  PubMed  PubMed Central  Google Scholar 

Butani L, Morgenstern BZ (2007) Long-term outcome in children after Henoch-Schonlein purpura nephritis. Clin Pediatr (Phila) 46:505–511. https://doi.org/10.1177/0009922806298896

Article  PubMed  Google Scholar 

Shi D, Chan H, Yang X, Zhang G, Yang H, Wang M, Li Q (2019) Risk factors associated with IgA vasculitis with nephritis (Henoch-Schonlein purpura nephritis) progressing to unfavorable outcomes: A meta-analysis. PLoS One 14:e0223218. https://doi.org/10.1371/journal.pone.0223218

Barbour SJ, Coppo R, Er L, Pillebout E, Russo ML, Alpers CE, Fogo AB, Ferrario F, Jennette JC, Roberts ISD, Cook HT, Ding J, Su B, Zhong X, Fervenza FC, Zand L, Peruzzi L, Lucchetti L, Katafuchi R, Shima Y, Yoshikawa N, Ichikawa D, Suzuki Y, Murer L, Wyatt RJ, Park C, Nelson RD, Narus JH, Wenderfer S, Geetha D, Daugas E, Monteiro RC, Nakatani S, Mastrangelo A, Nuutinen M, Koskela M, Weber LT, Hackl A, Pohl M, Pecoraro C, Tsuboi N, Yokoo T, Takafumi I, Fujimoto S, Conti G, Santoro D, Materassi M, Zhang H, Shi S, Liu ZH, Tesar V, Maixnerova D, Avila-Casado C, Bajema I, Barreca A, Becker JU, Comstock JM, Cornea V, Eldin K, Hernandez LH, Hou J, Joh K, Lin M, Messias N, Muda AO, Pagni F, Diomedi-Camassei F, Tokola H, D’Armiento M, Seidl M, Rosenberg A, Sannier A, Soares MF, Wang S, Zeng C, Haas M (2024) Histologic and Clinical Factors Associated with Kidney Outcomes in IgA Vasculitis Nephritis. Clin J Am Soc Nephrol 19:438–451. https://doi.org/10.2215/CJN.0000000000000398

Article  PubMed  Google Scholar 

Kidney Disease: Improving Global Outcomes Diabetes Work Group (2022) KDIGO 2022 clinical practice guideline for diabetes management in chronic kidney disease. Kidney Int 102:S1–S127. https://doi.org/10.1016/j.kint.2022.06.008

Article  Google Scholar 

Zhong X, Ding J (2023) Diagnosis and treatment of IgA nephropathy and IgA vasculitis nephritis in Chinese children. Pediatr Nephrol 38:1707–1715. https://doi.org/10.1007/s00467-022-05798-6

Article  PubMed  Google Scholar 

Ozen S, Marks SD, Brogan P, Groot N, de Graeff N, Avcin T, Bader-Meunier B, Dolezalova P, Feldman BM, Kone-Paut I, Lahdenne P, McCann L, Pilkington C, Ravelli A, van Royen A, Uziel Y, Vastert B, Wulffraat N, Kamphuis S, Beresford MW (2019) European consensus-based recommendations for diagnosis and treatment of immunoglobulin A vasculitis-the SHARE initiative. Rheumatology (Oxford) 58:1607–1616. https://doi.org/10.1093/rheumatology/kez041

Article  CAS  PubMed  Google Scholar 

Shi H, Deng P, Dong C, Lu R, Si G, Yang T (2022) Quality of evidence supporting the role of tripterygium glycosides for the treatment of diabetic kidney disease: an overview of systematic reviews and meta-analyses. Drug Des Devel Ther 16:1647–1665. https://doi.org/10.2147/DDDT.S367624

Article  PubMed  PubMed Central  Google Scholar 

Wu W, Cheng R, Boucetta H, Xu L, Pan JR, Song M, Lu YT, Hang TJ (2022) Differences in multicomponent pharmacokinetics, tissue distribution, and excretion of tripterygium glycosides tablets in normal and adriamycin-induced nephrotic syndrome rat models and correlations with efficacy and hepatotoxicity. Front Pharmacol 13:910923. https://doi.org/10.3389/fphar.2022.910923

Article  CAS  PubMed  PubMed Central  Google Scholar